Evidence map›Paper›PMID 31118283›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Gabriele Pizzolato, Hannah Kaminski, Marie Tosolini, Don-Marc Franchini, Fréderic Pont, Fréderic Martins, Carine Valle, Delphine Labourdette, Sarah Cadot, Anne Quillet-Mary and 9 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 144 papers.

0numbers the graph read from it
0cells of the map it votes in
144citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

144 citing papers in PubMed.

  1. Trial
  2. Review
  3. Enrichment of CD4iScience · 2026
    Article
  4. T Cell Thoughts.Immunological reviews · 2026
    Review
  5. Article
  6. γδ T cells show distinct responses to CMV after stem cell transplantation.Journal of molecular medicine (Berlin, Germany) · 2026
    Article
  7. Distinct CD8iScience · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

84 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Gabriele PizzolatoCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.
Hannah KaminskiUniversity of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, F-33076 Bordeaux, France.
Marie TosoliniCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.
Don-Marc FranchiniCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.
Fréderic PontCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.
Fréderic MartinsInstitut des Maladies Métaboliques et Cardiovasculaires, INSERM UMR1048, 31432 Toulouse, France.
Carine ValleCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.
Delphine LabourdettePlateforme GeT, Genotoul, 31100 Toulouse, France.
Sarah CadotCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.
Anne Quillet-MaryCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.ORCID 0000-0002-1849-6388
Mary PoupotCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.
Camille LaurentCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.
Loic YsebaertCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France.
Serena MeravigliaDepartment of Biopathology and Medical Biotechnologies, University of Palermo, 90133 Palermo, Italy.
Francesco DieliDepartment of Biopathology and Medical Biotechnologies, University of Palermo, 90133 Palermo, Italy.ORCID 0000-0002-6685-352X
Pierre MervilleUniversity of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, F-33076 Bordeaux, France.
Pierre MilpiedAix Marseille University, CNRS, INSERM, Centre d' Immunologie de Marseille-Luminy, 13007 Marseille, France.
Julie Déchanet-MervilleUniversity of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, F-33076 Bordeaux, France.
Jean-Jacques FourniéCentre de Recherches en Cancérologie de Toulouse, INSERM UMR1037, 31100 Toulouse, France; jean-jacques.fournie@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

γδ T lymphocytes represent ∼1% of human peripheral blood mononuclear cells and even more cells in most tissues of vertebrates. Although they have important anticancer functions, most current single-cell RNA sequencing (scRNA-seq) studies do not identify γδ T lymphocytes because their transcriptomes at the single-cell level are unknown. Here we show that high-resolution clustering of large scRNA-seq datasets and a combination of gene signatures allow the specific detection of human γδ T lymphocytes and identification of their T cell receptor (TCR)Vδ1 and TCRVδ2 subsets in large datasets from complex cell mixtures. In

Indexed as

AdultBase SequenceCD8-Positive T-LymphocytesCell ProliferationCells, CulturedHumansImmunologic MemoryKiller Cells, NaturalLeukocytes, MononuclearReceptors, Antigen, T-Cell, gamma-deltaSequence Analysis, RNAT-Lymphocyte SubsetsTranscriptomeReceptors, Antigen, T-Cell, gamma-deltacancerhuman immunologysingle-cell RNA-sequencingtranscriptomeγδ T lymphocyte

Identifiers

PMID31118283
PMCPMC6576116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.